Skip to main content
M

MyoWorks

The startup develops cost-effective scaffolding technology specifically for cultivated meat production, enabling companies to replicate the texture and structure of real meat. By providing these scaffolds, the company helps clients reduce reliance on traditional meat sources and lower production costs in the cultivated meat industry.

Nashik, IndiaFounded 2020102K+ followers
Updated 18 months ago

Funding

$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Cultivated meat production requires cost-effective scaffolding to support cell growth and differentiation, but existing options are either expensive, synthetically derived, or rely on animal-derived products, creating ethical concerns and hindering scalability. Replicating the complex multicellular architecture of real meat, including its texture, structure, and vasculature, remains a significant challenge.

Solution

MyoWorks provides edible, mycelium-based scaffolding materials designed to enhance the texture, structure, and bulk of cultivated meat products, offering a vegan and scalable alternative to traditional scaffolding methods. Their products facilitate cell adhesion, growth, and proliferation, addressing key challenges in cultivated meat production related to cost, ethics, and scalability. MyoWorks offers 2D and 3D scaffolds, along with versatile millicarriers to optimize cell culture in stirred tank bioreactors and shake flasks. They also develop food-relevant cell lines, ensuring high-quality standards through rigorous testing for contaminants.

Target Audience

MyoWorks primarily targets cultivated meat producers seeking cost-effective, ethical, and scalable scaffolding solutions to improve the texture and structure of their products.

Features

  • Mycelium-based 2D scaffolds for easier imaging and analysis of cellular interactions
  • Mycelium-based 3D scaffolds with biomimetic muscle-like parallel fibrous structure for enhanced cell adhesion and proliferation
  • Versatile mycelium-based millicarriers for enhanced cell growth in stirred tank bioreactors or shake flasks
  • Cell line development with rigorous mycoplasma and contamination testing
  • GRAS (Generally Recognized as Safe) material for all mycelium-based products
  • Scalable production to large quantities
  • Third-party validated scaffolds
This profile is AI-generated and may contain inaccuracies.